KNOBELMAN DEBORAH
SEC CIK 1931509 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SNTI | Senti Biosciences Holdings, Inc. | CFO, Head of Corp. Development | 131.0K | — | — | 2 | 2022-10-03 | 2024-02-01 |
Most active insiders at SNTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lu Timothy K | CEO, Dir | — | — |
| 2 | Rajangam Kanya | Pres, Chief Med, Dev. Off | — | — |
KNOBELMAN DEBORAH made no open-market trades at SNTI in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-02 | 2024-02-01 | SNTI | Senti Biosciences Holdings, Inc. | KNOBELMAN DEBORAH | CFO, Head of Corp. Development | A - Grant | $0.00 | +101.0K | 131.0K | +337% | $0 |
| D | 2022-10-04 | 2022-10-03 | SNTI | Senti Biosciences Holdings, Inc. | KNOBELMAN DEBORAH | CFO | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations